MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
1 other identifier
interventional
661
1 country
1
Brief Summary
This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 14, 2013
CompletedFirst Posted
Study publicly available on registry
January 16, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedJuly 22, 2015
July 1, 2015
1.2 years
January 14, 2013
July 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Determine the effect of the MeFirst tool, a tailored, online HPV vaccination decision-making guide, on HPV vaccination intention and/or uptake.
Intention will be assessed on a five-point scale immediately after and at 3 and 12 months. Uptake will be assessed by yes/no/don't know response to the statement, "I have received at least 1 dose of the HPV vaccine" at 3 and 12 months.
Immediately post intervention, 3 months and 12 months
Secondary Outcomes (1)
Determine the effect of the MeFirst tool on HPV-related knowledge.
Immediately post intervention, 3 months and 12 months
Other Outcomes (1)
Determine acceptability of the MeFirst tool to participants.
Immediately post intervention, 3 months and 12 months
Study Arms (2)
Centers for Disease Control and Prevention (CDC) Fact Sheet
NO INTERVENTIONParticipants will receive the CDC Fact sheet about HPV vaccination while they are taking the survey.
MeFirst Intervention
EXPERIMENTALParticipants will receive a tailored website regarding their own individualized risk for HPV and information about HPV Vaccination while they are taking the survey as opposed to receiving the CDC fact sheet. This tailored website is generated based on answers provided by each subject in the baseline survey.
Interventions
Participants will be lead through MeFirst, an interactive web-based tool that is tailored to their responses during the survey. This tool provides information regarding HPV Vaccination.
Eligibility Criteria
You may qualify if:
- enrolled at the University of Michigan
You may not qualify if:
- receipt of any doses of HPV vaccine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univeristy of Michigan
Ann Arbor, Michigan, 48109, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Vanessa K Dalton, MD, MPH
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
January 14, 2013
First Posted
January 16, 2013
Study Start
January 1, 2013
Primary Completion
April 1, 2014
Study Completion
April 1, 2014
Last Updated
July 22, 2015
Record last verified: 2015-07